442 related articles for article (PubMed ID: 11329777)
1. [Role of Chemotherapy in head and neck cancer].
Kohno N; Kitahara S
Gan To Kagaku Ryoho; 2001 Apr; 28(4):448-53. PubMed ID: 11329777
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy for head and neck cancer].
Kohno N; Kitahara S
Gan To Kagaku Ryoho; 2000 Feb; 27(2):177-82. PubMed ID: 10700887
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy of head and neck cancer].
Kohno N; Nakazawa E; Kusunoki M; Nishiya M
Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
6. [Role of neoadjuvant chemotherapy for management of resectable head and neck cancer].
Horiuchi M; Tamura Y; Miyake H
Gan To Kagaku Ryoho; 1994 Mar; 21(4):417-24. PubMed ID: 8129381
[TBL] [Abstract][Full Text] [Related]
7. [Attempts to improve organ preservation in patients with squamous cell carcinoma of the head and neck].
Taguchi T; Tsukuda M
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2030-4. PubMed ID: 16352924
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
9. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
[TBL] [Abstract][Full Text] [Related]
10. Overview of platinum chemotherapy in head and neck cancer.
Forastiere AA
Semin Oncol; 1994 Oct; 21(5 Suppl 12):20-7. PubMed ID: 7527591
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin combinations in the treatment of head and neck cancer.
al-Sarraf M
Semin Oncol; 1994 Oct; 21(5 Suppl 12):28-34. PubMed ID: 7992064
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer.
Cho YH; Lee SH; Kim DW; Wu HG; Hah JH; Rhee CS; Sung MW; Kim KH; Heo DS
Head Neck; 2008 Mar; 30(3):346-50. PubMed ID: 17972310
[TBL] [Abstract][Full Text] [Related]
13. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community.
Maguire PD; Meyerson MB; Neal CR; Hamann MS; Bost AL; Anagnost JW; Ungaro PC; Pollock HD; McMurray JE; Wilson EP; Kotwall CA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):698-704. PubMed ID: 14967423
[TBL] [Abstract][Full Text] [Related]
14. Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck.
Faivre S; Marti A; Rixe O; Janot F; Julieron M; Gatineau M; Temam S; Armand JP; Domenge C; Luboinski B; Raymond E
Head Neck; 2005 Apr; 27(4):311-9. PubMed ID: 15700290
[TBL] [Abstract][Full Text] [Related]
15. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
[TBL] [Abstract][Full Text] [Related]
16. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA
J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?
Specenier PM; Vermorken JB
Cancer Lett; 2007 Oct; 256(2):166-77. PubMed ID: 17673364
[TBL] [Abstract][Full Text] [Related]
18. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
[TBL] [Abstract][Full Text] [Related]
19. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
Budach W; Hehr T; Budach V; Belka C; Dietz K
BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
